Go Pro
NYSE:A

Agilent Technologies (A) Stock Price, News & Analysis

Agilent Technologies logo
$150.57 +0.59 (+0.40%)
As of 03:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Agilent Technologies Stock (NYSE:A)

Advanced

Key Stats

Today's Range
$147.78
$151.59
50-Day Range
$128.77
$159.25
52-Week Range
$108.35
$163.75
Volume
1.14 million shs
Average Volume
2.25 million shs
Market Capitalization
$42.45 billion
P/E Ratio
29.64
Dividend Yield
0.68%
Price Target
$170.33
Consensus Rating
Moderate Buy

Company Overview

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories. In the 2010s the company refocused its businesses through a separation that resulted in a dedicated electronic measurement company, allowing Agilent to prioritize analytical and diagnostic technologies. Over time Agilent has expanded its capabilities and product lines to address increasingly complex analytical challenges faced by its customers.

Headquartered in Santa Clara, California, Agilent serves a broad international customer base across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Its customers include pharmaceutical and biotechnology companies, academic and government research institutions, clinical and diagnostic labs, environmental and food-safety testing organizations, and industrial manufacturers. The company is managed by an executive leadership team and a board of directors that oversee its global operations and strategic direction.

AI Generated. May Contain Errors.

Agilent Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
97th Percentile Overall Score

A MarketRank™: 

Agilent Technologies scored higher than 97% of companies evaluated by MarketBeat, and ranked 13th out of 912 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Agilent Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.85, and is based on 1 strong buy rating, 15 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside Potential

    Agilent Technologies has a consensus price target of $170.33, representing about 12.8% upside from its current price of $151.05.

  • Amount of Analyst Coverage

    Agilent Technologies has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Agilent Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Agilent Technologies are expected to grow by 9.19% in the coming year, from $6.20 to $6.77 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Agilent Technologies is 29.77, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.27.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Agilent Technologies is 29.77, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.98.

  • Price to Earnings Growth Ratio

    Agilent Technologies has a PEG Ratio of 2.30. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Agilent Technologies has a P/B Ratio of 5.78. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Agilent Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    1.83% of the float of Agilent Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Agilent Technologies has a short interest ratio ("days to cover") of 3.77, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Agilent Technologies has recently decreased by 10.07%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Agilent Technologies has a dividend yield of 0.67%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Agilent Technologies has been increasing its dividend for 9 years.

  • Dividend Coverage

    The dividend payout ratio of Agilent Technologies is 20.08%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 15.07% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.

  • Read more about Agilent Technologies' dividend.
  • News Sentiment

    Agilent Technologies has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 31 news articles for Agilent Technologies this week, compared to 9 articles on an average week.
  • Search Interest

    Only 24 people have searched for A on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Agilent Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

A Stock News Headlines

Agilent Technologies Target of Unusually High Options Trading (NYSE:A)
FDA Momentum is Building Around NNVC!
NanoViricides (NYSE: NNVC) just received regulatory approval to begin a Phase II trial of NV-387 Oral Gummies for Ebola in the DRC, now the country's largest outbreak on record with over 4,100 cases. NV-387 uses a host-mimetic nanoviricide platform designed to trap and neutralize viruses. Noble Capital Markets recently initiated coverage on NNVC with an Outperform rating and a $6 price target.tc pixel
Agilent launches new laboratory solutions in India
Agilent: The Recovery Is Real, But So Is The Valuation
Agilent Introduces the Cary 635 FTIR Spectrometer
See More Headlines

A Stock Analysis - Frequently Asked Questions

Agilent Technologies' stock was trading at $136.24 at the beginning of 2026. Since then, A stock has increased by 10.9% and is now trading at $151.0540.

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings data on Wednesday, August, 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. The business's revenue for the quarter was up 8.1% on a year-over-year basis.
Read the conference call transcript
.

Agilent Technologies subsidiaries include Resolution Bioscience, BioTek Instruments, ACEA BIO, Young In Scientific Co. Ltd, ProZyme Inc, ULTRA Scientific, Genohm, and others.

Top institutional investors of Agilent Technologies include California State Teachers Retirement System (19.32%), BlackRock Inc. (9.06%), Massachusetts Financial Services Co. MA (3.54%) and Wellington Management Group LLP (2.64%). Insiders that own company stock include Michael R Mcmullen, Henrik Ancher-Jensen, Heidi Fields, Dominique Grau, Daniel K Podolsky, Padraig Mcdonnell, Rodney Gonsalves, Philip Binns and Judy L Brown.
View institutional ownership trends
.

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilent Technologies investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and iShares Micro-Cap ETF (IWC).

Company Calendar

Record date for 7/22 Dividend
6/30/2026
Ex-Dividend for 7/22 Dividend
6/30/2026
Dividend Payable
7/22/2026
Last Earnings
8/26/2026
Today
9/04/2026
Citi’s 2026 Global TMT Conference
9/10/2026
Fiscal Year End
10/31/2026
Next Earnings (Estimated)
11/23/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:A
CIK
1090872
Employees
18,100
Year Founded
1999

Price Target and Rating

High Price Target
$190.00
Low Price Target
$135.00
Potential Upside/Downside
+12.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.85
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
$5.08
Trailing P/E Ratio
29.69
Forward P/E Ratio
24.33
P/E Growth
2.3
Net Income
$1.30 billion
Net Margins
19.53%
Pretax Margin
22.49%
Return on Equity
24.45%
Return on Assets
13.09%

Debt

Debt-to-Equity Ratio
0.50
Current Ratio
2.05
Quick Ratio
1.56

Sales & Book Value

Annual Sales
$6.95 billion
Price / Sales
6.12
Cash Flow
$6.61 per share
Price / Cash Flow
22.83
Book Value
$26.12 per share
Price / Book
5.78

Miscellaneous

Outstanding Shares
281,930,000
Free Float
N/A
Market Cap
$42.53 billion
Optionable
Optionable
Beta
1.24

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NYSE:A) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners